CERo Therapeutics
CERO----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: CERo Therapeutics(CERO) the EBIT is -4.846 M (+5.11%);the EPS is -0.205 (+99.36%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B5.11%
----
----
EPS
-0.204799.36%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf